Quince Therapeutics, Inc.
QNCX
$0.9905
-$0.0095-0.95%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 40.78M | 47.85M | 59.45M | 67.82M | 75.06M |
| Total Receivables | 882.00K | 995.00K | 964.00K | 971.00K | 993.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 986.00K | 1.41M | 725.00K | 910.00K | 1.17M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.38M | 1.47M | 2.30M | 735.00K | 214.00K |
| Total Current Assets | 44.04M | 51.72M | 63.44M | 70.44M | 77.44M |
|
|
|||||
| Total Current Assets | 44.04M | 51.72M | 63.44M | 70.44M | 77.44M |
| Net Property, Plant & Equipment | 813.00K | 767.00K | 800.00K | 810.00K | 619.00K |
| Long-term Investments | -- | -- | -- | 17.25M | 17.63M |
| Goodwill | -- | -- | -- | 17.25M | 17.63M |
| Total Other Intangibles | 60.05M | 464.00K | 450.00K | 62.25M | 63.67M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 9.51M | 73.49M | 70.06M | 8.47M | 8.47M |
| Total Assets | 114.48M | 126.52M | 134.83M | 159.29M | 167.90M |
|
|
|||||
| Total Accounts Payable | 2.90M | 1.62M | 2.41M | 2.07M | 2.03M |
| Total Accrued Expenses | 3.97M | 3.50M | 2.54M | 2.63M | 3.12M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 96.00K | 101.00K | 94.00K | 93.00K | 64.00K |
| Total Finance Division Other Current Liabilities | 308.00K | 198.00K | 5.28M | 5.05M | 4.36M |
| Total Other Current Liabilities | 308.00K | 198.00K | 5.28M | 5.05M | 4.36M |
| Total Current Liabilities | 7.28M | 5.43M | 10.32M | 9.84M | 9.57M |
|
|
|||||
| Total Current Liabilities | 7.28M | 5.43M | 10.32M | 9.84M | 9.57M |
| Long-Term Debt | 14.32M | 14.90M | 13.83M | 13.52M | 13.43M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 394.00K | 450.00K | 453.00K | 480.00K | 321.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 62.34M | 60.81M | 63.25M | 61.28M | 59.49M |
| Total Liabilities | 84.33M | 81.59M | 87.86M | 85.12M | 82.82M |
|
|
|||||
| Common Stock & APIC | 406.65M | 405.53M | 404.40M | 403.15M | 401.68M |
| Retained Earnings | -376.47M | -364.01M | -358.52M | -330.79M | -319.64M |
| Treasury Stock & Other | -35.00K | 3.42M | 1.09M | 1.83M | 3.05M |
| Total Common Equity | 30.15M | 44.93M | 46.97M | 74.18M | 85.08M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 30.15M | 44.93M | 46.97M | 74.18M | 85.08M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 30.15M | 44.93M | 46.97M | 74.18M | 85.08M |
|
|
|||||